DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Bosutinib
Bosutinib
Bosutinib (Bosulif®) (“Boe SUE Ti Nib”)
Bosutinib
The Effects of Combination Treatments on Drug Resistance in Chronic Myeloid Leukaemia: an Evaluation of the Tyrosine Kinase Inhibitors Axitinib and Asciminib H
Second Generation Inhibitors of BCR- ABL for the Treatment of Imatinib- Resistant Chronic Myeloid Leukaemia
Characteristics of Trials and Regulatory Pathways Leading to US Approval Of
Bosutinib (Bosulif®)
Bosutinib (Bosulif) National Drug Monograph October 2015 VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives
Recommendations of the 99Th SEC (Oncology & Haematology)
QT Prolongation of All Kinase Inhibitors
Repurposing of Anticancer Drugs: in Vitro and in Vivo Activities Against Schistosoma Mansoni Noemi Cowan1,2 and Jennifer Keiser1,2*
Bosutinib for Pretreated Patients with Chronic Phase Chronic Myeloid Leukemia: Primary Results of the Phase 4 BYOND Study
[Product Monograph Template
Tyrosine Kinase Inhibitor (TKI) Flow Chart for the Treatment Of
New Targets in Endocrine-Resistant Hormone Receptor–Positive Breast Cancer
Bosutinib-Related Pneumonitis
HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer
1 Bosutinib Chronic Myeloid Leukaemia
Drug Discovery Model Using Molecular Orbital Computations: Tyrosine Kinase Inhibitors Clifford Fong
Top View
Kinase Drug Discovery 20 Years After Imatinib: Progress and Future Directions
Table 1: Drug-Drug Interactions of Common Cardiac Drugs and Chemotherapeutic Agents*
Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades
Bosutinib (Bosulif) for Chronic Myeloid Leukemia
Safety and Efficacy of Second-Line Bosutinib for Chronic Phase Chronic Myeloid Leukemia Over a Five-Year Period: Final Results of a Phase I/II Study
Tyrosine Kinase Inhibitors and Acute Pancreatitis
Bladder Cancer
Clinical Pharmacology of Tyrosine Kinase Inhibitors Becoming Generic
PF-00299804 Bosutinib Axitinib
Class Effects of Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia
Pulmonary Arterial Hypertension Associated with Protein Kinase Inhibitors: a Pharmacovigilance- Pharmacodynamic Study
Pulmonary Arterial Hypertension Associated with Protein Kinase Inhibitors: a Pharmacovigilance–Pharmacodynamic Study
Specialty Pharmacy Distribution Network for IBRANCE® (Palbociclib), INLYTA® (Axitinib), XALKORI® (Crizotinib), BOSULIF® (Bosutinib), and SUTENT® (Sunitinib Malate)
Application of Drug–Metal Ion Interaction Principle In
Global Target Profile of the Kinase Inhibitor Bosutinib in Primary
Oncology Comprehensive Drug List Krogerspecialtypharmacy.Com
SAFE HANDLING of HAZARDOUS DRUGS Updated 5/22/2020
Adult Antiemetic Management of Chemotherapy-Induced Nausea